Impact of intranasal budesonide on immune inflammatory responses and epithelial remodeling in chronic upper airway inflammation
Authors:
- Koichi NakanoKNKoichi Nakano
- Carlo VancheriCVCarlo Vancheri
- 1 July 2003
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 112 (1) , 37-44
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cellsImmunology, 2001
- Murine models define the role of TGF-β as a master regulator of immune cell functionCytokine & Growth Factor Reviews, 2000
- Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm☆☆☆Journal of Allergy and Clinical Immunology, 1999
- Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model.Journal of Clinical Investigation, 1998
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung.Journal of Clinical Investigation, 1997
- Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonideClinical Otolaryngology, 1995
- Differential effect of transforming growth factor β on the synthesis of Th1‐ and Th2‐like lymphokines by human T lymphocytesEuropean Journal of Immunology, 1992
- A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trialJournal of Allergy and Clinical Immunology, 1992
- Epithelial damage in nasal polypsClinical & Experimental Allergy, 1984